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ABSTRACT
Family with sequence similarity (FAM46) proteins
are newly identified metazoan-specific poly(A) poly-
merases (PAPs). Although predicted as Gld-2-like eu-
karyotic non-canonical PAPs, the detailed architec-
ture of FAM46 proteins is still unclear. Exact biolog-
ical functions for most of FAM46 proteins also re-
main largely unknown. Here, we report the first crys-
tal structure of a FAM46 protein, FAM46B. FAM46B
is composed of a prominently larger N-terminal cat-
alytic domain as compared to known eukaryotic
PAPs, and a C-terminal helical domain. FAM46B re-
sembles prokaryotic PAP/CCA-adding enzymes in
overall folding as well as certain inter-domain con-
nections, which distinguishes FAM46B from other
eukaryotic non-canonical PAPs. Biochemical analy-
sis reveals that FAM46B is an active PAP, and prefers
adenosine-rich substrate RNAs. FAM46B is uniquely
and highly expressed in human pre-implantation em-
bryos and pluripotent stem cells, but sharply down-
regulated following differentiation. FAM46B is local-
ized to both cell nucleus and cytosol, and is indis-
pensable for the viability of human embryonic stem
cells. Knock-out of FAM46B is lethal. Knock-down
of FAM46B induces apoptosis and restricts pro-
tein synthesis. The identification of the bacterial-like
FAM46B, as a pluripotent stem cell-specific PAP in-
volved in the maintenance of translational efficiency,
provides important clues for further functional stud-
ies of this PAP in the early embryonic development
of high eukaryotes.
INTRODUCTION
PAPs are a branch of the nucleotidyltransferase (NTase) su-
perfamily (1). Previous structural studies have established
close relationship between PAPs andCCA-adding enzymes,
another group of template-independent RNA polymerase
(2). Eukaryotic PAPs share sequence similarity to the class-I
archaeal CCA-adding enzymes, whereas bacterial PAPs are
*To whom correspondence should be addressed. Tel: +86 02087343168; Fax: +86 02087343180; Email: gaosong@sysucc.org.cn
Correspondence may also be addressed to Huang-Tian Yang. Tel: +86 021 54923280; Fax: +86 021 54923280; Email: htyang@sibs.ac.cn
Correspondence may also be addressed to Wei Chen. Tel: +86 0755 88010849; Email: chenw@sustech.edu.cn
†The authors wish it to be known that, in their opinion, the first four authors should be regarded as Joint First Authors.
Present address: Wei Sun, Department of Pharmaceutical Chemistry and Cardiovascular Research Institute, University of California San Francisco, CA 94158,
USA.
C© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work
is properly cited. For commercial re-use, please contact journals.permissions@oup.com
2734 Nucleic Acids Research, 2020, Vol. 48, No. 5
homologous to the class-II eukaryotic and bacterial CCA-
adding enzymes (3). Eukaryotic PAPs can be classified into
two subgroups. The ‘canonical’ PAPs, represented by nu-
clear PAP, are responsible for adding long poly(A) tail
during mRNAmaturation. They are composed of three do-
mains: an N-terminal catalytic domain containing the sig-
nature NTase motif, a central domain and a C-terminal
RNA-binding domain (RBD). The ‘non-canonical’ PAPs,
including but not limited to Gld-2, terminal uridylyltrans-
ferase (TUTs) and mitochondrial (mt-)PAP, add poly(A)
tails or short terminal tails to a variety of RNA substrates
including mRNA, snRNA, miRNA, aberrant rRNA and
snoRNA (4). Given the diversity of their substrate prefer-
ence, these non-canonical PAPs are recently renamed ter-
minal nucleotididyltranferase (TENTs) (5). TENTs usually
share a bipartite core PAP domain that lacks the RBD, and
have different accessory domains to fulfil their diverse func-
tions (4).
Most of the known eukaryotic PAPs are localized in the
nucleus, and their activity and specificity relies on the asso-
ciation with other co-factors. For example, PAP functions
as a component of the cleavage and polyadenylation speci-
ficity factor (CPSF) complex (6). Caenorhabditis elegans
(ce)Gld-2 separately forms complex with Gld-3 or RNP-
8 to control gamete sex (7). In contrast, bacterial PAPs
polyadenylate mRNAs in a non-discriminativemanner, and
usually require no partner (8,9). In terms of overall struc-
ture, bacterial PAPs are characterized by a seahorse-like
shape, where the catalytic head domain is linearly aligned
with the neck, body and tail domains involved in substrate
RNAbinding (9). This domain organization is distinct from
that of eukaryotic PAPs.
Family with sequence similarity 46 (FAM46) is a group
of predicted NTases found mainly in vertebrates (1). Hu-
man and mice both have four FAM46 proteins: namely
FAM46A/B/C/D (also named TENT5A/B/C/D) (10).
The amino acid sequences of these homologs share >40%
overall sequence identity, but are not apparently associated
with other protein families. Prior bioinformatics analysis
suggested that the FAM46 proteins are non-classical PAPs
(11), which was supported by a recent study on FAM46C,
a putative suppressor for multiple myeloma (12). However,
the detailed biological roles of other FAM46 proteins and
the structural feature of this protein family still remain un-
clear.
Most eukaryotic mRNAs carry poly(A) tails, whose
length is closely coupled with translational efficiency and
mRNA stability (13). These tails are firstly added by nuclear
PAPs during transcription termination, and usually short-
ened by deadenylases (14,15). The poly(A) tails can also be
re-extended in the cytoplasm, which may promote transla-
tion and inhibit decay of certain mRNAs (16–18). This tail-
length regulatory mechanism is considered to be an impor-
tant regime of translation control in the early development
of metazoan (19,20). A cytoplasmic PAP, Gld-2, was found
to be responsible for this process during gametogenesis in
C. elegans (21),Drosophila (22) andXenopus (23). However,
the cytoplasmic polyadenylation process is less understood
in mammalian early embryos, partly due to the lack of in-
formation on corresponding PAPs.
In this study, we started from structure determination and
revealed that FAM46B is a robust bacterial-like PAP. Be-
ing specifically expressed in human pluripotent stem cells,
FAM46B is critical for cell viability, possibly by maintain-
ing the stability of certain mRNAs. These results expand
the knowledge of eukaryotic PAPs, and provide new insight
into the translational control in early development of mam-
mals.
MATERIALS AND METHODS
Protein expression and purification
The cDNAs of Xenopus tropicalis (xt), Homo sapiens
(hs)FAM46B and Thermotoga maritima CCA adding en-
zyme (tmCCA) were purchased from YouBio. All con-
structs and mutants were expressed from a modified
pET28 vector with an N-terminal His6-tag fusion fol-
lowed by a PreScission protease (PSP) cleavage site. Re-
combinant plasmids were transformed into Escherichia coli
Rosetta (DE3) cells. Transformed bacteria were cultured at
37◦C in Terrific Broth (TB) medium until OD600 reached
0.6, and then induced with 0.1 mM isopropyl-1-thio--
D-thiogalactopyranoside (IPTG). Induced bacteria were
grown overnight at 18◦C. Cells were lysed in 50mMHEPES
pH 7.5, 500 mM NaCl, 30 mM imidazole, 5 mMMgCl2, 5
mM KCl, 1 mM phenylmethanesulfonylfluoride (PMSF),
1 M DNase I and 2 mM -mercaptoethanol (-ME) us-
ing a cell disruptor (JNBIO) and subjected to centrifuga-
tion at 40 000g for 1 h. The supernatant was filtered and
applied to a Ni-NTA (first Ni-NTA) column (GE Health-
care) equilibrated with binding buffer A containing 20 mM
HEPES pH 7.5, 500 mM NaCl, 30 mM imidazole, 2 mM
MgCl2, 2 mM KCl and 2 mM -ME. The column was ex-
tensively washed with buffer A and shortly with 20 mM
HEPES pH 7.5, 500 mM NaCl, 70 mM imidazole, 2 mM
MgCl2, 2 mM KCl and 2 mM -ME. Proteins were eluted
with 20mMHEPES pH7.5, 500mMNaCl, 300mM imida-
zole, 2 mMMgCl2, 2 mM KCl and 2 mM -ME before in-
cubated with 20 g glutathione S-transferase (GST)-fused
PSP to remove the His6-tag and dialyzed overnight against
binding buffer B containing 20 mM HEPES pH 7.5, 300
mM NaCl, 2 mM MgCl2, 2 mM KCl and 2 mM -ME.
After dialysis, PSP was removed using a GST column. The
protein was re-applied to a second Ni-NTA column equili-
brated with binding buffer B, and eluted with binding buffer
A. Eluted proteins were concentrated and loaded onto a
HiLoad 16/60 Superdex 200 column (GEHealthcare) equi-
librated with gel filtration buffer containing 20mMHEPES
pH 7.5, 150 mM NaCl, 2 mM MgCl2, 2 mM KCl and 1
mM dithiothreitol (DTT). Peak fractions corresponding to
monomeric FAM46B were collected. tmCCA was purified
as previously described (24), plus an extra ion-exchange step
using a Resource Q column (GE Healthcare) to remove the
nucleic acids bound to the protein. Cell lysis and protein
purification were performed at 4◦C.
Crystallization and structure determination
Crystals of xtFAM46B were obtained via hanging vapor
diffusion by mixing 10 mg ml−1 protein with equal volume
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Table 1. Crystallographic data collection and refinement
xtFAM46B
Data collection
Space group P 1211
Cell dimensions
a, b, c (A˚) 59.6, 76.1, 135.1
, ,  (◦) 90, 96.5, 90
Wavelength (A˚) 0.97915
Resolution (A˚)a 47.1–2.69 (2.79–2.69)
No. reflections 33266 (3214)
Rsym 0.083 (0.439)
I / (I) 14.12 (3.65)
Completeness (%) 99.2 (97.6)
Redundancy 3.41 (3.36)
Refinement
Rwork/Rfree 0.204/0.252
No. atoms
Protein 7988
Ligand/ion 39
Water 40
B-factors
Protein 63.18
Ligand/ion 100.96
Water 44.02
R.m.s. deviations
Bond lengths (A˚) 0.002
Bond angles (◦) 0.54
Ramachandran
Favored (%) 96.5
Outliers (%) 0
aNumbers in parentheses represent values from the highest resolution
shell.
of reservoir solution containing 2% tacsimate pH 5.0, 0.15
M sodium citrate tribasic dehydrate pH 5.6 and 10% PEG
3350 at 10◦C. During flash-cooling of the crystals in liquid
N2, a cryo-solution containing 0.15 M sodium citrate trib-
asic dehydrate pH 5.6, 15% (w/v) PEG3350 and 10% glyc-
erol was used. Diffraction datasets were collected at beam-
line BL19U1 of the Shanghai Synchrotron Radiation Facil-
ity (SSRF) and processed using the XDS suite (25). Phases
were solved by molecular replacement using MolRep (26)
with the atomic coordinate of mouse FAM46C (will be re-
ported elsewhere) as search model. The structural model
was built using COOT (27) and refined with Refmac5 (28)
and Phenix (29). Structural validation was carried out us-
ing MolProbity (30). Structural illustrations were prepared
using the PyMOL Molecular Graphics Systems (version
1.7.0.0, Schro¨dinger LLC; http://www.pymol.org/). Data
collection and refinement statistics can be found in Table
1.
In vitro CCA-adding assay
Truncated tRNAs (mini-tRNAs) with various three-termini
were used to substitute full-length immature andmature tR-
NAs in the in vitro CCA-adding assay according to a pre-
vious study (31). The mini-tRNAs (mini-tRNA-D, mini-
tRNA-DC and mini-tRNA-DCC), each conjugated with a
5′ biotin label, were purchased from Bioneer. For testing
AMP/CMP incorporation, 10 MFAM46B/C or tmCCA
was incubated with 10 M mini-tRNA and 200 M ATP
and/or CTP in a buffer containing 20 mMHEPES pH 7.5,
150 mM NaCl, 4 mM MgCl2 and 4 mM KCl at 37◦C for
50 min before analyzed by 22% urea-PAGE. The biotiny-
lated RNA substrates and products were incubated with
HRP-conjugated streptavidin and visualized by chemilumi-
nescence using the Chemiluminescent Nucleic Acid Detec-
tion Module Kit (Thermo Scientific) according to manu-
facturer’s protocol. All experiments were repeated at least
twice and the data showed satisfying consistency.
NTP consumption assay
16 M protein was incubated with 80 M A15 primer and
80 MNTP in a buffer containing 20 mMHEPES pH 7.5,
150 mMNaCl, 4 mMMgCl2 and 4 mMKCl at 37◦C for 20
min. The mixture was then analyzed by an HPLC system
(Agilent) equipped with a reverse phase C18 ODS-2 Hy-
persil analytical column preceded by a C18 guard column
(Thermo Scientific), with 100mMpotassium phosphate pH
6.5, 10 mM tetrabutyl ammonium bromide and 7.5% ace-
tonitrile as running buffer. Nucleotides were detected by ab-
sorption at 254 nm and quantified by integration of the cor-
responding peaks.
NMP incorporation assay
10 M protein was incubated with 10 M 5′-biotinylated
15-mer RNAprimer (Bioneer) and 200MNTP in a buffer
containing 20 mM HEPES pH 7.5, 150 mM NaCl, 4 mM
MgCl2 and 4 mM KCl at 37◦C for 50 min. The mixtures
were subjected to 20% urea–PAGE and the biotinylated
RNA substrates and products were visualized by Chemi-
luminescence. All experiments were repeated at least twice
and the data showed satisfying consistency.
Polyadenylation assay
10 M protein was incubated with 5 M 15-mer RNA
primer, 500 M ATP and 1 ul 1:1000 diluted [-32P]-ATP
(3000 Ci/mmol, PerkinElmer) at 37◦C for 50 min. The mix-
tures were subjected to 20% urea–PAGE. The low range
RNA marker (NEB) was pre-labeled with [ -32P]-ATP
(3000 Ci/mmol, PerkinElmer) using T4 polynucleotide ki-
nase (NEB). The gels were dried, exposed to a phospho-
rimaging plate, and scanned using a Typhoon phospho-
rimager (GE Healthcare). All experiments were repeated at
least twice and the data showed satisfying consistency.
Nucleotide binding assay
Binding of xtFAM46B to different adenosine nucleotides
were analyzed by using isothermal titration calorimetry
(ITC) at 25◦C in the buffer containing 20 mM HEPES pH
7.5, 150 mM NaCl, 4 mMMgCl2 and 4 mM KCl. 100 M
protein was titrated by 1 mM adenosine nucleotides with
20 injections, 2 l each. Resulting heat changes upon each
injection was integrated using the PEAQ-ITC program pro-
vided by the manufacturer.
In vitro A-tailing experiment
Independent triplicate experiments were performed by in-
cubating 5 M FAM46B with 5 M 15-mer random
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RNA (N15 RNA oligos, Integrated DNA Technologies)
in a buffer containing 20 mM HEPES pH 7.5, 150 mM
NaCl, 4 mM MgCl2 and 4 mM KCl at 37◦C for 50
min. After incubation, samples were extracted with acid-
phenol-chloroform pH 4.5 (Thermo Scientific), washed
twice with 80% ethanol and eluted into ddH2O before sub-
jected to 12% urea-PAGE. The poly(A)-added and poly(A)
non-added RNA fragments were separated, individually
pooled and extracted for preparing sequencing libraries
with TruSeq small RNA library preparation kit (Illumina).
Sequencing was performed on a Hiseq 2000 platform (Illu-
mina) with 1 × 50 nt format.
Data analysis for in vitro A-tailing experiment
For all reads from the sequencing data, the first 15 bases
were sub-stringed, and the index of the first 3 bases ‘TGG’
of the adapter was searched. The numbers of added A were
calculated as ‘the index number––15’, if 90% of the bases
were A between the first 15 bases and the adapter. If no
adapter was found and 90% of the bases were A after the
first 15 bases, then the number of A equals to 35. Reads
without added A (0A) were classed as background, whereas
reads with 5A or greater were classed as foreground. The
frequencies of ATCG at each position were calculated both
in background and foreground. At a particular position j,
of a sequence in foreground, p = (pA, pC, pG, pT) denoted
the probabilities of the four elements, and q= (qA, qC, qG,
qT) denoted the corresponding background probabilities.
Defining r = (rA, rC, rG, rT) by: ri = pi/qi (i = A, C, G,
T), the sequence logos were drawn using this metric at each
position at axis with ggseqlogo software (32).
Phylogenetic analysis
All protein sequences were downloaded from UniProt
(https://www.uniprot.org/) and aligned by using MAFFT
(https://www.ebi.ac.uk/Tools/msa/mafft/). Phylogenetic
tree of whole protein sequence was constructed by using
Bayesian Evolutionary Analysis Sampling Trees (BEAST)
program, version 1.8.4. Each protein sequence data set was
analyzed with the Blosum62 model, strict molecular clock
model and coalescent constant size. Sampling and conver-
gence of the runs were evaluated using the Tracer program,
version 1.6 (http://beast.community/tracer) until effective
sample size values exceeded 200 to ensure sufficient level
of sampling. The length of Bayesian Monte Carlo Markov
Chain (MCMC) was set 10 000 000, and sampled every
1000. States (the first 10%) were removed as burn-in. Maxi-
mum clade credibility trees were visualized with the FigTree
program, version1.4.3 (http://beast.community/figtree) and
iTOL (https://itol.embl.de/).
Bioinformatics analysis
The RNA-seq reads from published samples were mapped
by the STARmapper (33). The number of uniquely mapped
reads was calculated on each annotated gene, and further
normalized to fragment per kilobase per million (FPKM)
by total number of uniquely mapped reads. For part of the
ChIP-seq analysis, the raw sequencing reads of H3K4me3,
H3K27me3 and H3K27ac in H9 hESCs (34) were mapped
by bowtie 2 (35) with default parameter settings and
MACS2 software was further used for the peak calling.
The raw sequencing reads fromOCT4, NANOG and SOX2
ChIP-seq data in HUES64 hESCs (36) were mapped to
human genome (hg19) by bowtie 2 with default parame-
ter settings, and MACS2 software (37) was further used
for the peak calling. Graphics (for bioinformatics analy-
ses) were done inR (http://www.r-project.org/), and ggplot2
(http://ggplot2.org/) was used for part of the graph prepa-
ration. The ChIP-seq peaks were visualized in IGV.
Microarray
Three replicates from differentiating hESCs during
mesendodermal differentiation were used for RNA ex-
traction. Quality-assessed RNA samples were hybridized
to Affymetrix Gene Chip Human Gene 1.0 ST arrays
(Affymetrix). Twelve raw data files generated from the
Affymetrix scanner passed data quality control and were
further performed with RNA normalization through the
Affymetrix expression console. Further analysis was per-
formed using SAM (significance analysis of microarrays)
software (38).
hESC maintenance and mesendoderm induction
hESCs (H1 [Wi Cell Research Institute]) were maintained
in mTeSR1 media (Stem Cell Technologies) on Matrigel
(hESC qualified; Corning) coated dishes. Formesendoderm
induction, media were changed from mTeSR1 to chemi-
cally defined medium (CDM) supplemented with Activin
A (R&D Systems), BMP4 (bone morphogenetic protein 4,
R&D Systems), bFGF (basic fibroblast growth factor, In-
vitrogen) and LY294002 (phosphoinositide-3-kinase/AKT
serine/threonine kinase inhibitor, Sigma) at approximately
70% to 80% confluency (39,40).
In vitro differentiation assay
Embryoid body (EB) formationwas performed as described
previously (41). Briefly, hESCs were cultured on matrigel-
coated six-well plates. Cells from one well were dissociated
with collagenase IV (1 mg ml−1) for 5 min, and then split
into small cell clumps. The small cell clumps were trans-
ferred into three wells of low-attachment six-well plate, and
cultured in EB medium (knock-out DMEM, 20% knock-
out serum replacement, 1 mM L-glutamine, 1% nonessen-
tial amino acids, 0.1mM2-mercaptoethanol and primocin).
The medium was changed every 2 days. The embryoid bod-
ies were cultured for 8 days followed by collection for qRT-
PCR.
siRNA Transfection
Plates of 12-well (Corning) were coated with 400 l of di-
luted Matrigel before addition of siRNA oligos. siRNAs
(Qiagen) mixed with Opti-MEM I (GIBCO) were added
into the wells. For higher transfection efficiency, a mixture
of 2 l DharmaFect1 (Dharmacon) transfection reagent
with 98 l Opti-MEM I was added into each well after
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siRNA addition. After incubation for ∼30 min at room
temperature, single cell suspension of 2 × 106 hESCs in
800 l of mTeSR1 with 10 M Y-27632 (Stem Cell Tech-
nologies) was seeded into each well. 18 h later, Y-27632
was washed off. The working concentration of siRNA
was 100 nM. Six hours after washing off Y-27632, RNA
samples were collected for further assays unless specified.
The siRNA sense sequences are: 5′-UAAGGCUAUGAA
GAGAUAC (scramble), 5′-GGCGCCATTTGTCTTGGA
ATT (siRNA-1), 5′-CCGUGUGCCUCAUGAACCATT
(siRNA-2).
Western blot
Experiments were performed as described (42). Briefly, cells
were lysed in lysis buffer and cell lysate containing 30 g
protein was used for Western blots. Membranes were in-
cubated with the primary antibody against EOMES (Cat
No. ab23345, Abcam, 1:1000), FAM46B (Cat No. 23149-
1-AP, Proteintech, 1:1000), GAPDH (Cat No. sc-47724,
Santa Cruz Biotechnology, 1:5000), -Tubulin (Cat No.
30303ES50, YEASEN, 1:1000) and Laimin B1 (Cat No.
16048, Abcam, 1:1000). The membranes were then incu-
bated with IRDye 680LTDonkey anti-Rabbit IgG (Cat No.
926-68023, Li-CORBiosciences) or IRDye 800CWDonkey
anti-Mouse IgG (Cat No. 926-32212, Li-COR Biosciences)
as secondary antibodies and visualized on an Odyssey In-
frared Imager (Li-COR Biosciences).
CRISPR knock-in
To generate hESCs with the 3 × Flag-tagged FAM46B, a
two-step strategy was adopted, including (i) integration of
PGK-Puro-IS-3× Flag in the 5′ flanking region of the start
codon, and (ii) excision of the sequence between TTAA
by using an excision-only PiggyBac Transposase PBx, leav-
ing behind 3 × Flag sequence linked to the start codon of
FAM46B. Single clones were selected and one clone of the
hESCs with Flag-tagged FAM46B protein was confirmed
by sequencing and Western blot analysis.
Immunocytochemical staining
Immunofluorescence assay was performed according to the
protocol described previously (43). Briefly, the attached
cells were harvested at indicated stages, fixed with 4%
paraformaldehyde, permeabilized in 0.4% Triton X-100
(Sigma-Aldrich) for intracellular antigens, blocked in 10%
normal goat serum (Vector Laboratories), and then stained
with antibodies to FAM46B (Cat No. 23149-1-AP, Pro-
teintech, 1:200). Antibody labeling was visualized using
DyLight 488-conjugated secondary antibodies (all from
Jackson ImmunoResearch Laboratories, 1:1000). Nuclei
were counterstained with Hoechst 33258 (Sigma-Aldrich,
1:2000). A Zeiss Observer microscope was used for slide ob-
servation and image capture.
qRT-PCR
Total RNA was prepared using the RNAprep pure Mi-
cro Kit (TIANGEN) following the manufacturer’s instruc-
tions. cDNAs were generated by reverse-transcribed total
RNA (1 g) using ReverTra Ace reverse transcriptase (Toy-
obo). qRT-PCR was performed and analyzed by the ViiA™
7 Real-Time PCR System (Life Technologies) with SYBR
Green qPCR Master Mix (Roche). The qRT-PCR data
were shown as fold changes normalized to internal control
PBGD. The qRT-PCR primers are listed as follows:
Gene Primer sequence (5′-3′)
AT
(◦C)
PS
(bp)
FAM46B F-CCTGCCTACTAGACTTCCTGC 60 149
R-CTTGCCGCTCTTGTTGGACA
OCT4 F-AGTGAGAGGCAACCTGGAGA 60 81
R-ACACTCGGACCACATCCTTC
NANOG F-CATGAGTGTGGATCCAGCTTG 60 191
R-CCTGAATAAGCAGATCCATGG
SOX2 F-GGGAAATGGGAGGGGTGCAA
AAGAGG
60 151
R-TTGCGTGAGTGTGGATGGGA
TTGTG
PBGD F-ATTACCCCGGGAGACTGAAC 60 130
R-GGCTGTTGCTTGGACTTCTC
SOX1 F-ACCAGGCCATGGATGAAG 60 67
R-CTTAATTGCTGGGGAATTGG
GATA4 F-GGAAGCCCAAGAACCTGAAT 60 98
R-GTTGCTGGAGTTGCTGGAA
T F-ACCCAGTTCATAGCGGTGAC 60 165
R-CCATTGGGAGTACCCAGGTT
GAPDH F-AGCCACATCGCTCAGACAC 60 66
R-GCCCAATACGACCAAATCC
F, forward; R, reverse; AT, annealing temperature; PS, product size.
Flow cytometry
Cells were harvested at the indicated time points and stained
with an Annexin V-FITC Apoptosis Detection Kit (BD
Bioscience) to detect early apoptotic cells according to the
manufacturer’s instructions. Annexin V signals were de-
tected by flow cytometry using a FACStar Plus Flow Cy-
tometer (Becton-Dickinson).
MTT assay
A total of 1 × 105 hESCs per well were planted in 48-
well plates in mTeSR1 and transfected with scramble or
FAM46B siRNAs with the addition of Y-27632. Eighteen
hours after transfection, medium was changed to mTeSR1.
At 24, 30, 36 h after transfection, 10 l of 5 mg ml−1 MTT
[3-(4,5-dime-thylthiazolyl-2)-2,5-diphenyltetrazolium bro-
mide, Sangon Bio-tech] solution was added and incubated
for 4 h. DMSO (Sigma-Aldrich) was then added to solu-
bilize the formazan product and the absorbance was mea-
sured at 570 nm.
RNA half-life analysis
H1 cells were treated with doxycycline for 12 h before in-
cubation with 5 g ml−1 actinomycin D (ActD, Sigma-
Aldrich). Cells were collected at time points 0, 0.5, 1, 2, 3,
4 and 5 h after the addition of ActD. RNA was extracted
using TRIzol (Sigma-Aldrich). Reverse transcription was
performed with HiScript 1st Strand cDNA Synthesis Kit
(Vazyme) following the manufacture’s protocol. qRT-PCR
was conducted with SYBR green (Bio-Rad) on an Bio-Rad
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CFX96 PCR machine. The qRT-PCR data were shown as
fold changes normalized to internal control GAPDH. The
qRT-PCR primers not included in the qRT-PCR method
section are listed as follows:
Gene Primer sequence (5′-3′)
AT
(◦C)
PS
(bp)
Wnt5A F-CCCTTAGGCAGGTTGGCTTT 60 90
R-CACTGCAACTGAGGGGATGT
RICTOR F-TGCAGAAGCACCCTTCACAA 60 148
R-AGCCAGTTATAGCACAACCCC
SKP2 F-TGACATCGGATGCCCTCAAA 60 249
R-AAGCCAAATGGCATACCACAC
PAPBC4 F-TGCAAGGTGGTGTGTGATGA 60 70
R- CAGCCTCTTGGGTCTCGAAG
RPS25 F-GAAGATTCGAGGCTCCCTGG 60 128
R-CTGGAGCATCTCCACCCTTG
F, forward; R, reverse; AT, annealing temperature; PS, product size.
FUNCAT assay and click chemistry
FUNCAT assay was performed as previously described
(44). Briefly, 24 h after transfected with scramble or
FAM46B siRNAs, 1 × 105 hESC cells of each sample
were collected and lysed in ice-cold RIPA lysis buffer con-
taining protease inhibitor cocktail (Sigma). HPG incor-
porated protein lysates were labeled selectively with Cy5-
conjugated azide by copper-catalyzed azide-alkyne cycload-
dition (CuAAC). Click reaction was performed following
the protocol from Click Chemistry Protein Reaction Buffer
Kit (ClickChemistry Tools). Finally, samples were heated at
70◦C for 10 min before resolved by SDS-PAGE and imaged
using a pharos FXTM Plus Molecular Imager (Bio-Rad).
Loading consistency was confirmed by staining the gel with
Coomassie Blue after fluorescent imaging. All experiments
were repeated at least twice and the data showed satisfying
consistency.
CRISPR knock-out
The inducible Cas9 FAM46B-knock-out hESC was gener-
ated by transfecting gRNA targeting the exons of FAM46B
into the inducible Cas9 H1 cell line. Knock-out of FAM46B
was induced by addition of 1 g ml−1 doxycycline (Sigma-
Aldrich), and cells were collected at different time points
(0, 3, 6, 12, 24, 48 h) after doxycycline induction for analy-
sis. The knock-out effect was of verified by qRT-PCR and
Western blot using antibody against FAM46B. The gRNA
sequences are 5′-AAACTATCGGCCTTCCCCGGACGG
C-3′ (forward) and 5′-CACCGCCGTCCGGGGAAGGC
CGATA-3′ (reverse).
RESULTS
Overall crystal structure of FAM46B
In order to obtain functional clues of FAM46 proteins, we
solved a 2.7 A˚ crystal structure of nucleotide-free FAM46B
protein from Xenopus tropicalis (xtFAM46B) with a Rfree
of 0.252 (Table 1). In the structural model, residues 1−8,
198−200 and 347−350 are missing due to disordered con-
figuration. The protein contains an N-terminal catalytic
domain (NCD, residues 9−230 resolved in the structure)
and a C-terminal helical domain (HD, residues 231−346),
which together form a massive cleft (Figure 1A−C). Inside
the cleft, the three NTase consensus carboxylates, Asp91,
Asp93 and Glu167 are present at the putative catalytic site,
but we did not observe the electron density for catalytic
metal ion. A conserved Arg176 directs the loop linking the
two domains via hydrogen bonds and a salt bridge with
Thr234, Arg235O, Asn236O and Glu239 (Figure 1D). The
other side of the cleft is shielded by a salt bridge between
Lys90 from the NCD and Asp295 from the HD (Figure
1E). The bottom of the cleft is featured by an extensive hy-
drophobic network formed by residues from bothNCDand
HD (Figure 1F). Glu179 and Asp183 sit in the center of the
cleft and interact withLys247 protruding from theHD (Fig-
ure 1G).
The NCD is built of a central eight-stranded -sheet
(1−8) surrounded by seven -helices (1−7) involving
a typical NTase core (Figure 2A). An extended -hairpin,
composed of E1, E2 and an elongated connecting loop,
is situated between 1 and 2. This FAM46-specific -
hairpin stretches vertically to the central -sheet, and cov-
ers the valley created by 4, 5, 5 and 6 (Figure 2B).
Beside the NTase core, 7 is closely associated with 1,
3, 7 and 8 via hydrophobic interactions (Figure 2C).
The HD is composed of 5 -helices. 8, 9 and 10 are
packed into a triangle platform, whereas 11 and 12 form
an antiparallel pair underneath (Figure 2D). The five -
helices are tightly associated via hydrophobic interactions
(Figure 2E).
FAM46B is a bacterial-like PAP
The overall architecture of FAM46B does not conform to
the previously calculated FAM46C model (11). Compared
to other known eukaryotic PAPs such as the classical PAP
and non-classical Gld-2 or mt-PAP (45–47), the NCD of
FAM46B is double-sized in terms of amino acid residue
numbers, and contains more secondary elements (Supple-
mentary Figure S1A and B). To our knowledge, FAM46
proteins are likely to bear the largest catalytic domain
among all known PAPs. Compared to Gld-2, FAM46B has
a substantially wider NCD and deeper cleft (Supplemen-
tary Figure S1C and D). In addition, the relative posi-
tion of FAM46B NCD and HD also differs from that of
the catalytic domain and central domain of Gld-2 (Sup-
plementary Figure S1E). This somewhat ‘complex’ archi-
tecture of FAM46B, which is obviously distinguished from
other known eukaryotic PAPs, prompted us to look for its
other potential relatives in the Dali server (48). Intrigu-
ingly, FAM46B shows high topological similarity with the
class-II bacterial PAPs and CCA-adding enzymes. When
FAM46B is individually superimposed withEscherichia coli
PAP I (ecPAP) (9) and Thermotoga maritima CCA-adding
enzyme (tmCCA) (24,49), the root mean standard devia-
tion (r.m.s.d.) values of aligned C atoms are 2.93 A˚ and
3.65 A˚, respectively, although the sequence identity between
FAM46B and these two prokaryotic enzymes is only ∼15%
(Figure 3A and Supplementary Figure S2). In particular,
the central eight-stranded -sheet in the NCD is highly
consistent with the bacterial PAPs/CCA-adding enzymes,
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Figure 1. Overall structure of FAM46B. (A) Schematic representation showing the organization of crystallized construct based on full-length FAM46B.
NCD, N-terminal catalytic domain; HD, helical domain. Borders of each domain are indicated by residue numbers. (B) Structure of FAM46B. Domains
of FAM46B are indicated and colored as in A. The two featured -hairpin is colored gray. (C) Surface representation of FAM46B with the inter-domain
cleft indicated by dashed ellipse. (D–G) Interactions between NCD and HD. Side chains of involved residues are shown as ball-and-stick models in the
same color as the domains they belong to.
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Figure 2. Structural details of FAM46B domains. (A) Overall structure of NCD with secondary elements assigned. The NTase core is specified in orange.
(B) The ambient interactions of the featured -hairpin in FAM46BNCD. (C) The local hydrophobic cluster next to the NTase core. Side chains of involved
residues are shown as ball-and-stick models. (D) Overall structure of HD. (E) Hydrophobic interactions that stabilize HD.
2740 Nucleic Acids Research, 2020, Vol. 48, No. 5
A B
C
Figure 3. FAM46B is a bacterial-like PAP. (A) Structural comparison between FAM46B and ecPAP (left) or tmCCA (right). FAM46B (magenta) is sepa-
rately superimposed with ecPAP (Protein Data Bank code 3AQM, pale cyan) and tmCCA (3H39, teal). The r.m.s.d. values of aligned C atoms are shown.
The body and tail domains of ecPAP and tmCCA are colored grey. (B) The topology diagram of the FAM46B NCD (top), as compared with those of
the head domains of ecPAP (middle) and tmCCA (bottom), colored as in A. (C) The phylogenetic analysis revealing a close relationship between FAM46
proteins and bacterial PAPs. Subtypes of PAPs and CCAs are color-specified. Class I (cool colors) and II (warm colors) PAPs/CCAs are separated by a
dashed line.
and the HD of FAM46B also resembles their neck domains
(Figure 3A and B). The conserved inter-domain salt bridges
in ecPAP and tmCCA, which are shown to be involved in
the coordination of nucleotides (i.e. Asp151-Arg200 in ec-
PAP, and Asp130-Arg180 in tmCCA), are equivalent to the
aforementioned Glu179-Lys247 pair in FAM46B (Figure
1G and Supplementary Figure S3A). Phylogenetic analysis
also revealed that compared to eukaryotic PAPs, FAM46
proteins are more closely related to class-II bacterial PAPs
and CCA-adding enzymes (Figure 3C and Supplementary
Figure S3B).
Following this clue, we tested whether FAM46B and
FAM46C possess PAP and/or CCA-adding activities.
CCA-adding enzymes catalyze the consecutive 3′-terminal
CCA extension of precursor tRNAs with CTP and ATP
as donors, while PAPs selectively add a string of nontem-
plated AMPs to the 3′-end of target mRNAs by consum-
ing ATP molecules. 5′-biotinylated 15-mer poly(A) RNA
(A15) and mini-tRNA substrates were individually incu-
bated with FAM46B or FAM46C in the presence of corre-
sponding nucleotides, and the products were visualized us-
ing streptavidin-conjugated horseradish peroxidase (HRP).
Both proteins failed to add AMP or CMP to mini-tRNAs
lacking 3′ A, CA and CCA (Figure 4A). On the other hand,
FAM46B and FAM46C were able to elongate A15 in the
presence of Mg2+, and the lengths of the products were ap-
parently coupled to ATP concentration (Figure 4B). When
Mg2+ was replaced by Mn2+, both proteins became more
potent in catalyzing polyadenylation (Figure 4B). Notably,
FAM46B showedmuch higher PAP activity than FAM46C,
especially in Mg2+-present conditions. FAM46B is able to
efficiently extend oligoA substrates ranging fromA5 to A30,
but shows no apparent binding to AMP, ATP or ATPS
(Supplementary Figure S3C and D).
Nucleic Acids Research, 2020, Vol. 48, No. 5 2741
A B
Figure 4. FAM46B has PAP activity. (A) Test for CCA-adding activity for human FAM46B and mouse FAM46C. 10 M 5′-biotinylated mini-tRNA
primers with different 3′ tails as indicated were individually incubated with 10 M protein in the presence of 2 mM ATP or CTP for 50 min. tmCCA was
used as a positive control. (B) Polyadenylation activity for human FAM46B and mouse FAM46C. 10 M 5′-biotinylated A15 primer was incubated with
10 M FAM46B or FAM46C in the presence of 4 mMMg2+ or Mn2+ for 50 min. ATP was supplied with increasing concentrations as indicated.
tmCCA and ecPAP rely on two charged residues
(Asp174 and Arg177 in tmCCA; Asp194 and Arg197
in ecPAP), which are conserved among class-II bacterial
PAPs, in recognizing adenosine and cytosine nucleotides.
However, structural comparison between FAM46B and
tmCCA/ecPAP revealed that these two conserved residues
are not present in FAM46B (Supplementary Figure S3E).
Considering the lack of the nucleotide-binding affinity of
FAM46B that also differs from tmCCA and ecPAP, we in-
fer that FAM46B and FAM46C are bacterial-like poly(A)
polymerases in terms of overall folding but may possess a
different nucleotide binding manner from the class-II bac-
terial PAPs. In the rest part of the paper, human FAM46B
has been used for all the experiments.
The catalytic properties of FAM46B
To investigate the catalytic properties of FAM46B, we firstly
examined the nucleotide selection of FAM46B. An HPLC-
based method was developed to monitor the incorporation
of each monophosphate nucleotide (NMP). FAM46B and
A15 primer were individually incubated with correspond-
ing label-free triphosphate nucleotides (NTPs). After reac-
tion, the mixture was applied to a C18 column with an
upstream guard column to block the protein and RNA
primer/product (Figure 5A). Thus, we were able to moni-
tor the consumption of NTPs by quantifying the remain-
ing nucleotides. When ATP was supplied, we observed de-
creased area of the ATP peak but no AMP peak after in-
cubation, suggesting that ATP has been hydrolyzed and
added to the A15 primer (Supplementary Figure S4A). In
contrast, UTP, CTP or GTP was barely consumed under
the same conditions (Figure 5B and Supplementary Fig-
ure S4B). Consistent with the HPLC assay, FAM46B only
extends 5′-biotinylated A15 in the presence of ATP (Figure
5C).
In order to figure out whether FAM46B has preference
on the oligonucleotide primers, we compared the ATP con-
sumption of FAM46B in the presence of A15, A14U1 or
U14A1. For three cases, the remaining ATP portions were
approximately 10%, 30%and 90%, respectively (Figure 5D).
Similar results were observed in AMP incorporation assay
using -32P-labeled ATP ([-32P]-ATP), where A14U1 led
to less AMP incorporation than A15, and U14A1 showed
only little ATP incorporation (Figure 5E). To further ex-
plore the potential sequence preference of FAM46B over
the substrates, we used a pool of random sequences of 15
nt as primers for an in vitro adenosine (A)-tailing assay
(Supplementary Figure S5). It turned out that FAM46B in-
deed prefers an AxAA sequence at 3′-end of the substrates
(Figure 5F). Further experiments indicated that FAM46B
extended A15 primer in a ATP/protein concentration-
dependent manner, and the majority of poly(A) products
were below 150 nt in length (Figure 5G). These results sug-
gest that FAM46B has strong selectivity on RNAmolecules
that are adenosine-rich close to 3′-end, and the base type at
the very 3′-end of substrate RNA also impacts polyadeny-
lation efficiency.
The catalytic center and potential RNA-binding area of
FAM46B
All NTases contain three critical motifs in the catalytic cen-
ter: hG[GS], [DE]h[DE]h and h[DE]h (h indicates a hy-
drophobic amino acid). To verify these functional motifs in
FAM46B, we mutated corresponding key residues, namely
Gly107, Ser108, Asp124, Asp126 and Glu200, individually
into alanine and performed AMP incorporation and ATP
consumption assays (Figure 6A). Unexceptionally, these
mutants failed to hydrolyze ATP in the presence of A15,
and lost polyadenylation activity (Figure 6B and C). We
also did mutagenesis analysis for the residues involved in
NCD-HD interaction (Figure 1D−G). Except for Lys123
(corresponding to Lys90 in xtFAM46B as shown in Figure
1E), mutation of other selected residues at NCD-HD inter-
face substantially reduced PAP activity of FAM46B (Figure
6D).
Surface electrostatic potential analysis reveals that
positively-charged patches exist around the catalytic center
of FAM46B (Figure 6E). The mutations of patch-involving
residues Lys175, Lys202, Arg209, Arg274, Lys280 and
His329 to alanine all deprived the PAP activity of FAM46B.
In contrast, the mutation of Arg302, an HD residue located
at the opposite side of the central cleft, still remained par-
tially active (Figure 6F). We also tested two non-charged
residues close to the positively charged patches, namely
Cys180 and Phe330. C180A had reduced PAP activity, and
F330A was as potent as the wild type (Figure 6F). These
data suggest that these positively-charged patches may be
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Figure 5. The substrate sequence preference of FAM46B. (A) Schematic drawing showing the experimental process of HPLC-based NTP consumption
assay. (B) Consumption of different NTPs by human FAM46B. Results from two independent experiments are presented. (C) In vitro polyadenylation
assay showing FAM46B extends 5′-biotinylated A15 primer only in the presence of ATP. (D) ATP consumption of FAM46B in the presence of different
RNA primers. (E) Polyadenylation assay showing the AMP incorporation to different RNA primers by FAM46B. (F) Position-dependent nucleotide
frequency of substrates extended by FAM46B. (G) Progressive polyadenylation activity of FAM46B, shown by ATP (left panel) or protein (right panel)
concentration-dependent ATP incorporation in the presence of A15 primer.
involved in the RNA binding. Similarly, the neck domain
of ecPAP also possesses a positively-charged area that has
been proved critical for RNA binding (9).
FAM46B is specifically expressed during human early devel-
opment
In order to get an overview of the expression profile of
FAM46 family members during mammalian early embryo-
genesis, we analyzed single-cell RNA-seq data of human
and mouse pre-implantation embryos (50,51). FAM46B
and FAM46C are maternal genes, and highly expressed in
human embryos before zygotic genome activation (ZGA)
(Supplementary Figure S6A). Similar transcriptional dy-
namics was observed also for mouse Fam46 family during
early development (Supplementary Figure S6B). Follow-
ing ZGA, the transcription level of FAM46B and FAM46C
is sharply decreased. Interestingly, in contrast to Fam46b
in mouse embryos, FAM46B is reactivated in human blas-
tocyst, uniquely and highly expressed in human epiblast
(Supplementary Figure S6A and B). We then investigated
the transcription specificity of FAM46 members by com-
paring large RNA-seq datasets of multiple human embry-
onic stem cell (hESC) lines and human induced pluripotent
stem cell (hiPSC) lines togetherwith various cancer cell lines
and somatic tissues (Figure 7A). The analysis showed that
FAM46B is uniquely expressed in hESCs and hiPSCs, but
not in cancer or somatic cells.
Consistent with FAM46B transcription in human
pluripotent cells, ChIP-seq data shows that, in contrast to
FAM46A/C/D, the promoter region of FAM46B is marked
with transcriptionally active histone marks (H3K4me3,
H3K27ac). Notably, the co-binding site of pluripotency
transcription factors OCT4 and NANOG is embedded in
the intron of FAM46B, indicating FAM46B transcription
might directly regulated by OCT4 and NANOG (Figure
7B). These data imply a strong coupling between FAM46B
expression and human pluripotency.
Expression of FAM46B is coupled to human pluripotency
To explore the pattern of FAM46B transcription during
hESC differentiation, we first employed a typical sponta-
neous differential model: embryoid body formation. The
quantitative real-time PCR (qRT-PCR) results showed that
FAM46B expression level was gradually declined during
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Figure 6. Critical sites of FAM46B for polyadenylation activity. (A) The NTase core of FAM46B. The consensus NTase motif is highlighted as cartoon
representation in orange. The conserved key residues are shown as sticks-and-ball models. (B) ATP consumption of mutants regarding key residues shown
in A. Results from two independent experiments are presented. (C) AMP incorporation of mutants regarding residues shown in A. (D) Polyadenylation
activity of human FAM46B mutants regarding residues located in the interface between NCD and HD. (E) Surface electrostatic potential of xtFAM46B.
Conserved negatively charged residues that may be involved in RNA binding, together with two hydrophobic residues close to the catalytic center, are
specified. Corresponding residues of human FAM46B are indicated in the parentheses. (F) AMP incorporation of mutants regarding residues shown in D.
embryoid formation (Figure 7C). Importantly, FAM46B
is also down-regulated in neuroectodermal and mesendor-
mal cells differentiated from hESCs (52), indicating that
FAM46B inactivation might be required for lineage specifi-
cation and germ layer formation during the embryonic de-
velopment in humans (Supplementary Figure S6C).
As FAM46B is still expressed in the early time of
mesendoderm differentiation (Supplementary Figure S6C),
we analyzed its transcription dynamics in detail during the
mesendoderm differentiation from hESCs. We noticed that
the mRNA level of FAM46B showed approximately 5-,
11- and 15-fold decrease at 24, 48 and 72 h after induced
differentiation, respectively (Figure 7D). In contrast, the
mRNA levels of FAM46A/C/D, as well as other known
canonical and non-canonical PAPs, remained steady. Sub-
sequent qRT-PCR analysis confirmed that the mRNA
level of FAM46B sharply declines following mesendoder-
mal induction (Figure 7E). In order to monitor the en-
dogenous FAM46B protein, we knocked-in a 3 × Flag-
tag to the 5′ end of FAM46B reading frame (Supplemen-
tary Figure S6D). Western blot analysis indicated that the
FAM46B protein level decreased in a time-dependent man-
ner upon mesendodermal induction (Figure 7F). We also
examined the transcriptional dynamics of FAM46 family
during human somatic cell reprogramming (53). Intrigu-
ingly, FAM46B expression level is gradually increased fol-
lowing pluripotency acquisition, while FAM46A is gradu-
ally decreased, and FAM46C/D are not expressed during
the whole reprogramming process (Supplementary Figure
S6E). Altogether, these data suggest that FAM46B is specif-
ically expressed in human pluripotent cells and may play
crucial roles in human pluripotent cells.
FAM46B is essential for the viability of hESCs
To explore the biological role of FAM46B, we tested
its subcellular localization in hESCs. Immunofluorescent
staining indicated a ubiquitous distribution of endoge-
nous FAM46B (Figure 8A). Subsequent nuclear/cytosolic
fractionation assay revealed a cytoplasmic preference of
FAM46B residence, though it also appeared in the nu-
clear fraction (Figure 8B). Given the differentiation-
coupled down-regulation feature of FAM46B, we investi-
gated whether FAM46B is directly associated with pluripo-
tency maintenance of hESCs. Knock-down of FAM46B by
siRNAs did not significantly alter the mRNA levels of the
pluripotency-related genesOCT4, NANOG and SOX2 (Fig-
ure 8C and Supplementary Figure S7A and B). On the
other hand, instead of causing cell differentiation, FAM46B
knock-down severely deteriorated viability of hESCs as
soon as within 30 h, as indicated by MTT assays (Fig-
ure 8D), and the growth defect was clearly observable un-
der microscope (Supplementary Figure S7C). According
to the flow cytometry analysis, apoptotic hESCs (charac-
terized by the annexin+ proportion) were increased after
a 24-hour treatment of FAM46B siRNA (Figure 8E and
Supplementary Figure S7D). We also tried to knock out
FAM46B in human embryonic cells using CRISPR/Cas9
2744 Nucleic Acids Research, 2020, Vol. 48, No. 5
A
B
D E F
C
Figure 7. FAM46B is specifically expressed in human pluripotent stem cells. (A) Expression profiles of FAM46 family genes in 12 hESC (H1, H6 and
H9), 25 hiPSC samples, 32 normal somatic tissues and 6 cancer cell lines. The rows represent the transcription FAM46 family genes. The RNA-seq data
from ENCODE was analyzed, and the RNA expression level was shown as FPKM (fragment per kilobase per million reads). (B) The comparison of
chromatin status and pluripotent transcription factor binding sites around the promoters of FAM46 family genes. The promoter of FAM46B is bound by
pluripotent transcription factors OCT4, NANOG and SOX2, and marked with transcriptionally active histone marks H3K4me3 and H3K27ac. (C) The
mRNA level of FAM46B is gradually decreased during embryoid formation. Fold changes relative to day 0 are plotted for Day 2–8. Error bar indicate s.d.
(D) Microarray data showing the relative expression alteration of FAM46 genes together with other canonical (PAPα, PAPβ and PAPγ ) and noncanonical
PAPs (PAPD4/Gld-2,PAPD5,PAPD7 andmt-PAP) at various time points after induced differentiation of hESCs.Note the declining tendency of FAM46B.
Fold changes relative to day 0 are plotted for Day 1−3. Error bar indicate s.d. (E) Relative mRNA levels of FAM46B at various time points after induced
differentiation determined by qPCR. mRNA level of FAM46B at day 0 is set to 1. Error bar indicates s.d. (n = 3). (F) FAM46B protein levels at various
time points after induced differentiation determined by Western blot. EOMES is the marker for mesendoderm differentiation.
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Figure 8. Characterization of FAM46B in hESCs. (A) Subcellular localization of endogenously expressed FAM46B protein in hESCs shown by immunoflu-
orescent staining. Scale bar, 5 M. (B) Cytosolic (C)/nuclear (N) fractionation experiment showing the subcellular localization of endogenous flag-tagged
FAM46B in hESCs. (C) Knock-down of FAM46B did not significantly alter the expression level of OCT4, NANOG and SOX2. Error bar indicates s.d.
(n = 3). (D) Knock-down of FAM46B inhibits cell viability in MTT assay. (E) Flow-cytometry assay showing knock-down of FAM46B leads to hESC
apoptosis. Significance was calculated with two-sided Student’s t-test (n = 3). **P < 0.01, ***P < 0.001. (F) mRNA half-life of selected genes in response
to conditional knock-out of FAM46B in hESCs. Inhibition of cellular transcription by adding ActD was set to time point 0 and indicated by an arrow. (G)
Model showing that FAM46B promotes translation in pluripotent cells.
system. The surviving hESCs had at a least one chromo-
some copy intact, while perished hESCs had frame-shift in-
sertions or deletions (data not shown) on FAM46B induced
by Cas9 for both chromosome copies. These results suggest
that FAM46B may not be directly involved in pluripotency
maintenance, but is essential for the viability of hESCs.
To understand how FAM46B affects the viability of
hESCs, we checked whether FAM46B plays a role in pro-
tein synthesis by using the fluorescent non-canonical amino
acid labeling (FUNCAT) strategy (Supplementary Figure
S8). In order to avoid severe cell death, hESCs had to be
collected at 24 h after transfection of siRNAs. Newly syn-
thesized proteins were labeled using homopropargylglycine
(HPG) and detected via click chemistry. When FAM46B
was knocked-down, the amount of newly synthesized pro-
teins in hESCs was somewhat declined (Supplementary
Figure S8B). We measured mRNA half-life of 8 selected
genes, which are functionally linked with FAM46 proteins
or mediate pluripotency, in FAM46B conditional knock-
out hESCs. Within 5 h of treatment of actinomycin D,
mRNA levels ofWnt5A,NANOG, FAM46B, RICTOR and
SKP2 were substantially declined, whereas those of other
genes remained relatively steady (Figure 8F, Supplementary
Figure S8C). These data indicate that FAM46B may be in-
volved in maintaining the translation efficiency of at least
some genes in hESCs through preventing degradation of
their mRNAs (Figure 8G).
DISCUSSION
In this study, we have identified FAM46B as a novel type of
eukaryotic non-classical PAP. The striking structural simi-
larity with bacterial PAP distinguishes FAM46B from other
known eukaryotic PAPs. Consistently, FAM46B also shares
2746 Nucleic Acids Research, 2020, Vol. 48, No. 5
similar functional properties with its bacterial relatives but
not eukaryotic non-classical PAPs, as proven by our bio-
chemical analysis. First, like bacterial PAPs, FAM46B ac-
tively catalyzes polyadenylation without extra partners in
vitro. For eukaryotic ceGld-2, a partner (ceGld-3) is indis-
pensable for its enzymatic efficiency, as ceGld-3 promotes
the stability of ceGld-2 by sheltering a hydrophobic area
on its surface, and provides extra interface for binding the
RNA substrate (46). While FAM46B has no prominent hy-
drophobic area on the surface, and its large NCD contains
plenty of potential RNA binding sites, a Gld-3-like partner
thus seems unnecessary for FAM46B. Second, although fa-
voring A-rich over U-rich sequence, FAM46B lacks strict
discrimination on RNA substrates at least in vitro. This is
also a feature inherited from bacterial PAP (8).
These bacterial-like features of FAM46B provide valu-
able clues for explaining the biological role of FAM46B.
The early embryos of metazoans are transcriptionally in-
active, which entails robust cytoplasmic polyadenylation to
stabilize the mRNAs and increase translational efficiency
(19,20). Except for FAM46B reported in this study, only
a couple of eukaryotic cytoplasmic PAP have been identi-
fied and characterized, such as Gld-2 (4). While Gld-2 is
essential in C. elegans, Drosophila and Xenopus, knock-out
of this PAP shows no visible phenotype in mice (54). This
evidence implies that, other PAPs functionally overlapping
Gld-2 are likely to exist in mammals. Given the fact that
FAM46B is an active PAP with endogenously cytoplasmic
localization and unique and dynamic expression profile in
human pre-implantation embryos and hESCs/hiPSCs, it is
tempting to speculate that FAM46B is involved in cytoplas-
mic polyadenylation of mRNA in the early stage of human
embryogenesis. Interestingly, FAM46B and FAM46C have
been found to be essential for the meiosis in mammalian
oocytes (55). Re-analysis of single-cell RNA-seq datasets
of human germline and embryonic development covering
stages from primordial germ cells (PGCs) to hatched blas-
tocyst indicates that the mRNA levels of FAM46B and
FAM46C dramatically increase in PGCs and the zygote
stage of early development, till ZGA initiation (50,56).
These studies imply that FAM46B and/or FAM46C may
function as early as during gametogenesis. According to
our results, FAM46B is most likely involved in the overall
translational control of the hESCs without significantly al-
tering the transcriptional profile. Given its potent PAP ac-
tivity, a reasonable speculation is that FAM46B may coun-
terbalance the deadenylation of mRNAs to maintain the
poly(A) tail length of mRNAs at a steady level (14,15), so as
to ensure the translational efficiency. Understanding the de-
tailed mechanism on how FAM46B influence translation in
hESCs required future studies based on transcriptome-wide
characterization of mRNA poly(A) tail-lengths and quan-
titative proteomics.
The prominent negative correlation between expression
level and cell differentiation suggests that FAM46B is not
all-time needed during the embryonic development. The
mRNA level of FAM46B in Xenopus shows high consis-
tency: it grows steadily from two-cell stage until blastula
stage and then sharply dives to almost zero (57). Thus, it
is possible that FAM46B also functions in non-mammals.
On the other hand, functions of Gld-2 are mostly described
in gametogenesis (21–23), and its mRNA level remains un-
changed after hESC differentiation. FAM46B and Gld-
2 may account for cytoplasmic polyadenylation in differ-
ent situations of early animal development. This arouses
interesting questions: why the animal embryos require a
bacterial-like PAP before they run into complexity? To an-
swer this question, future studies are demanded to reveal
the exact RNA substrates and putative regulatory factors
of FAM46B, for which many possibilities need to be con-
sidered. For instance, some non-classical PAPs are found
to catalyze the addition of single nucleotide to microRNAs
(58), or require non-protein partners (59). In addition, it
might be worthwhile to seek the connections between early
animal embryos and bacteria in the control of poly(A) tail
length. In contrary to eukaryotes, polyadenylation in bacte-
ria usually leads to the degradation of regulatoryRNAs and
eventually causes translation inhibition (8). In this context,
the observation that hESCs are extraordinarily sensitive to
FAM46B depletion is somewhat analogous to the situation
in bacteria: even moderate overexpression of PAP I is lethal
to E. coli (60).
The crystal structure of FAM46B provides important
clues in the future research of FAM46 proteins. Cytoplas-
mic polyadenylation is suggested to be active in early ani-
mal embryos and neuronal synapses (18). Coincidently, ex-
isting evidence of FAM46 proteins reveals its relationship
with development and neuronal disorders. It has been re-
ported that FAM46A is expressed in tooth germs and may
be involved in the formation of tooth enamel (61). Muta-
tions in FAM46A are found responsible for several auto-
somal recessive disorders in humans, including osteogen-
esis imperfecta and retinitis pigmentosa (62–64). Overex-
pression of FAM46D is closely associated with autism spec-
trum disorder-like behaviors in a mouse model (65). Hu-
man FAM46B shows 55%, 55% and 43% sequence identity
to human FAM46A, FAM46C and FAM46D, respectively,
which implies that these FAM46 proteins would share ex-
tensive structural and biochemical similarity to FAM46B.
Thus, the feature as bacterial-like PAPs is the key to un-
derstand the functional mechanisms of FAM46 proteins in
their various biological roles.
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